OPK Stock Price History and Quote Analysis Insights for Investors
OPKO Health, Inc.
Stock Price Today
OPKO Health, Inc. (OPK) stock declined over -0.63%, trading at $1.58 on NASDAQ, down from the previous close of $1.59. The stock opened at $1.61, fluctuating between $1.58 and $1.64 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare to physician offices, clinics, hospitals, employers and governmental units; and a novel diagnostic instrument system to provide blood test results in the point-of-care setting, as well as 4Kscore prostate cancer testing services. Its Pharmaceutical segment offers Rayaldee to treat secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease, and vitamin D insufficiency; OPK88004, an orally administered selective androgen receptor modulator; OPK88003, a once-weekly administered peptide for the treatment of type 2 diabetes and associated obesity that is in Phase IIb trials; and hGH-CTP, a once-weekly human growth hormone injection that completed Phase III clinical trial in partnership with Pfizer, Inc. This segment develops and commercializes longer-acting proprietary versions of already approved therapeutic proteins. The company also offers specialty APIs; develops, manufactures, markets, and sells pharmaceutical, nutraceutical, veterinary, and ophthalmic products; commercializes food supplements and over the counter products; manufactures and sells products primarily in the generics market; and imports, markets, distributes, and sells pharmaceutical products in a range of indications, including cardiovascular products, vaccines, antibiotics, gastro-intestinal products, hormones, and others. In addition, it operates pharmaceutical platforms in Ireland, Chile, Spain, and Mexico. The company was founded in 1991 and is headquartered in Miami, Florida.
Company Information
| Employees | 3930 |
| Beta | 1.65 |
| Sales or Revenue | $863.50M |
| 5Y Sales Change% | -0.347% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Medical - Diagnostics & Research |
Frequently Asked Questions
OPKO Health, Inc. (NASDAQ: OPK) stock price is $1.58 in the last trading session. During the trading session, OPK stock reached the peak price of $1.64 while $1.58 was the lowest point it dropped to. The percentage change in OPK stock occurred in the recent session was -0.63% while the dollar amount for the price change in OPK stock was -$0.01.
The NASDAQ listed OPK is part of Medical - Diagnostics & Research industry that operates in the broader Healthcare sector. OPKO Health, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Dr. Arie Gutman
Pres of API
Mr. Steven D. Rubin Esq., J.D.
Executive Vice President of Admin. & Director
Dr. Gary J. Nabel M.D., Ph.D.
Chief Innovation Officer & Director
Dr. Jane H. Hsiao M.B.A., MBA, Ph.D.
Vice Chairman & Chief Technical Officer
Dr. Elias Adam Zerhouni M.D.
Pres & Vice Chairman
Mr. Adam E. Logal
Senior Vice President, Chief Financial Officer, Chief Accounting Officer & Treasurer
Mr. James DeMarco
Senior Vice President of Pharmaceutical Sales
Dr. Akhtar Ashfaq
Senior Vice President of Clinical R&D and Medical Affairs
Dr. David Okrongly Ph.D.
Pres of OPKO Diagnostics
Dr. Charles W. Bishop
Chief Executive Officer of OPKO Renal
Dr. Jon R. Cohen M.D.
Chief Executive Officer & Director
Ms. Jane Pine Wood Esq., J.D.
Chief Legal Officer of Bio-Reference Laboratories
Dr. Phillip Frost Ph.D.
Chairman & Chief Executive Officer
OPK's closing price is 85.88% higher than its 52-week low of $0.85 where as its distance from 52-week high of $1.75 is -9.71%.
Number of OPK employees currently stands at 3,930.
Official Website of OPK is: https://www.opko.com
OPK could be contacted at phone 305 575 4100 and can also be accessed through its website. OPK operates from 4400 Biscayne Boulevard, Miami, FL 33137, United States.
OPK stock volume for the day was 2.63M shares. The average number of OPK shares traded daily for last 3 months was 3.96M.
The market value of OPK currently stands at $1.08B with its latest stock price at $1.58 and 682.48M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2024 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com